{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:44:15Z","timestamp":1792172655715,"version":"4.4.0"},"reference-count":50,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>ABSTRACT Autoimmune encephalitis (AIE) is one of the most common causes of noninfectious encephalitis. It can be triggered by tumors, infections, or it may be cryptogenic. The neurological manifestations can be either acute or subacute and usually develop within six weeks. There are a variety of clinical manifestations including behavioral and psychiatric symptoms, autonomic disturbances, movement disorders, and seizures. We reviewed common forms of AIE and discuss their diagnostic approach and treatment.<\/jats:p>","DOI":"10.1590\/0004-282x20170176","type":"journal-article","created":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T00:01:16Z","timestamp":1516492876000},"page":"41-49","source":"Crossref","is-referenced-by-count":103,"title":["Autoimmune encephalitis: a review of diagnosis and treatment"],"prefix":"10.1590","volume":"76","author":[{"given":"L\u00edvia Almeida","family":"Dutra","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil; Hospital Israelita Albert Einstein, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Abrantes","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Fieni","family":"Toso","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz","family":"Pedroso","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando Graziani Povoas","family":"Barsottini","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Hoftberger","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study","volume":"10","author":"Granerod J","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable MS","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus F","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000245","article-title":"CSF herpes virus and autoantibody profiles in the evaluation of encephalitis","volume":"3","author":"Linnoila JJ","year":"2016","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater L","year":"2014","journal-title":"Lancet Neurol"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens: pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster E","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.autrev.2013.10.016","article-title":"Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system","volume":"13","author":"Coevorden-Hameete MH","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","article-title":"Autoimmune Encephalitis","volume":"8","author":"Leypoldt F","year":"2013","journal-title":"Eur Neurol Rev"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/epi.12276","article-title":"Autoimmunity, seizures, and status epilepticus","volume":"54","author":"Davis R","year":"2013","journal-title":"Epilepsia"},{"issue":"20","key":"ref10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin WO","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti- N -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau J","year":"2007","journal-title":"Ann Neurol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau J","year":"2011","journal-title":"Lancet Neurol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer MJ","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt SE","year":"2012","journal-title":"Neurology"},{"issue":"24","key":"ref15","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"H\u00f6ftberger R","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol M","year":"2014","journal-title":"Lancet Neurol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola M","year":"2017","journal-title":"Neurology"},{"issue":"24","key":"ref18","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa T","year":"2014","journal-title":"J Neurosci"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster E","year":"2010","journal-title":"Lancet Neurol"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger R","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster E","year":"2011","journal-title":"Neurology"},{"issue":"18","key":"ref22","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","article-title":"The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies","volume":"86","author":"Sonderen A","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.seizure.2013.06.004","article-title":"VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications","volume":"22","author":"Lilleker JB","year":"2013","journal-title":"Seizure"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani SR","year":"2012","journal-title":"Ann Neurol"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"van Sonderen A","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster E","year":"2011","journal-title":"Ann Neurol"},{"issue":"14","key":"ref27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"Sonderen A","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1083\/jcb.200305018","article-title":"Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1","volume":"162","author":"Poliak S","year":"2003","journal-title":"J Cell Biol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"Sonderen A","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"1-2","key":"ref30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2015.10.024","article-title":"Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies","volume":"359","author":"Vale TC","year":"2015","journal-title":"J Neurol Sci"},{"issue":"22","key":"ref31","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/01.wnl.0000436617.40779.65","article-title":"Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders","volume":"81","author":"Alexopoulos H","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1684\/epd.2016.0797","article-title":"Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes","volume":"18","author":"Khawaja AM","year":"2016","journal-title":"Epileptic Disord"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz A","year":"2008","journal-title":"Brain"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies","volume":"72","author":"Ari\u00f1o H","year":"2015","journal-title":"JAMA Neurol"},{"issue":"16","key":"ref35","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson M","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon A","year":"2013","journal-title":"JAMA Neurol"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies","volume":"71","author":"Ari\u00f1o H","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor \u03b11 subunit in patients with isolated optic neuritis","volume":"72","author":"Martinez-Hernandez E","year":"2015","journal-title":"JAMA Neurol"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras J","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat A","year":"2013","journal-title":"Ann Neurol"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi E","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"18","key":"ref42","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig C","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","article-title":"Metabotropic glutamate receptor type 1 autoimmunity","volume":"86","author":"Lopez-Chiriboga AS","year":"2016","journal-title":"Neurology"},{"issue":"18","key":"ref44","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster E","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas N","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm L","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force","volume":"18","author":"Titulaer MJ","year":"2011","journal-title":"Eur J Neurol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau J","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2009.336","article-title":"Positron emission tomography-computed tomography in paraneoplastic neurologic disorders","volume":"67","author":"McKeon A","year":"2010","journal-title":"Arch Neurol"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent A","year":"2011","journal-title":"Lancet Neurol"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v76n1\/0004-282X-anp-76-1-0041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T22:35:02Z","timestamp":1603665302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2018000100041&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0004-282X2018000100041"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20170176","relation":{},"ISSN":["1678-4227","0004-282X"],"issn-type":[{"value":"1678-4227","type":"electronic"},{"value":"0004-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}